Literature DB >> 22618881

Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort.

Sabrina Schlesinger1, Krasimira Aleksandrova, Tobias Pischon, Veronika Fedirko, Mazda Jenab, Elisabeth Trepo, Paolo Boffetta, Christina C Dahm, Kim Overvad, Anne Tjønneland, Jytte Halkjær, Guy Fagherazzi, Marie-Christine Boutron-Ruault, Franck Carbonnel, Rudolf Kaaks, Annekatrin Lukanova, Heiner Boeing, Antonia Trichopoulou, Christina Bamia, Pagona Lagiou, Domenico Palli, Sara Grioni, Salvatore Panico, Rosario Tumino, Paolo Vineis, H B Bueno-de-Mesquita, Saskia van den Berg, Petra H M Peeters, Tonje Braaten, Elisabete Weiderpass, J Ramón Quirós, Noémie Travier, María-José Sánchez, Carmen Navarro, Aurelio Barricarte, Miren Dorronsoro, Björn Lindkvist, Sara Regner, Mårten Werner, Malin Sund, Kay-Tee Khaw, Nicholas Wareham, Ruth C Travis, Teresa Norat, Petra A Wark, Elio Riboli, Ute Nöthlings.   

Abstract

General obesity has been positively associated with risk of liver and probably with biliary tract cancer, but little is known about abdominal obesity or weight gain during adulthood. We used multivariable Cox proportional hazard models to investigate associations between weight, body mass index, waist and hip circumference, waist-to-hip and waist-to-height ratio (WHtR), weight change during adulthood and risk of hepatocellular carcinoma (HCC), intrahepatic (IBDC) and extrahepatic bile duct system cancer [EBDSC including gallbladder cancer (GBC)] among 359,525 men and women in the European Prospective Investigation into Cancer and Nutrition study. Hepatitis B and C virus status was measured in a nested case-control subset. During a mean follow-up of 8.6 years, 177 cases of HCC, 58 cases of IBDC and 210 cases of EBDSC, including 76 cases of GBC, occurred. All anthropometric measures were positively associated with risk of HCC and GBC. WHtR showed the strongest association with HCC [relative risk (RR) comparing extreme tertiles 3.51, 95% confidence interval (95% CI): 2.09-5.87; p(trend) < 0.0001] and with GBC (RR: 1.56, 95% CI: 1.12-2.16 for an increment of one unit in WHtR). Weight gain during adulthood was also positively associated with HCC when comparing extreme tertiles (RR: 2.48, 95% CI: 1.49-4.13; <0.001). No statistically significant association was observed between obesity and risk of IBDC and EBDSC. Our results provide evidence of an association between obesity, particularly abdominal obesity, and risk of HCC and GBC. Our findings support public health recommendations to reduce the prevalence of obesity and weight gain in adulthood for HCC and GBC prevention in Western populations.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 22618881     DOI: 10.1002/ijc.27645

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  62 in total

Review 1.  Is That Possible to Stop or Cease the NASH to Turn into HCC?

Authors:  Ahmet Uygun
Journal:  J Gastrointest Cancer       Date:  2017-09

2.  Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies.

Authors:  Peter T Campbell; Christina C Newton; Cari M Kitahara; Alpa V Patel; Patricia Hartge; Jill Koshiol; Katherine A McGlynn; Hans-Olov Adami; Amy Berrington de González; Laura E Beane Freeman; Leslie Bernstein; Julie E Buring; Neal D Freedman; Yu-Tang Gao; Graham G Giles; Marc J Gunter; Mazda Jenab; Linda M Liao; Roger L Milne; Kim Robien; Dale P Sandler; Catherine Schairer; Howard D Sesso; Xiao-Ou Shu; Elisabete Weiderpass; Alicja Wolk; Yong-Bing Xiang; Anne Zeleniuch-Jacquotte; Wei Zheng; Susan M Gapstur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-03-17       Impact factor: 4.254

Review 3.  Nonalcoholic fatty liver disease and hepatocellular carcinoma.

Authors:  Stephanie Klein; Jean-François Dufour
Journal:  Hepat Oncol       Date:  2017-10-30

4.  Anthropometric Risk Factors for Cancers of the Biliary Tract in the Biliary Tract Cancers Pooling Project.

Authors:  Sarah S Jackson; Alison L Van Dyke; Bin Zhu; Ruth M Pfeiffer; Jessica L Petrick; Hans-Olov Adami; Demetrius Albanes; Gabriella Andreotti; Laura E Beane Freeman; Amy Berrington de González; Julie E Buring; Andrew T Chan; Yu Chen; Gary E Fraser; Neal D Freedman; Yu-Tang Gao; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Eric J Grant; Francine Grodstein; Patricia Hartge; Mazda Jenab; Cari M Kitahara; Synnove F Knutsen; Woon-Puay Koh; Susanna C Larsson; I-Min Lee; Linda M Liao; Juhua Luo; Emma E McGee; Roger L Milne; Kristine R Monroe; Marian L Neuhouser; Katie M O'Brien; Ulrike Peters; Jenny N Poynter; Mark P Purdue; Kim Robien; Dale P Sandler; Norie Sawada; Catherine Schairer; Howard D Sesso; Tracey G Simon; Rashmi Sinha; Rachael Z Stolzenberg-Solomon; Shoichiro Tsugane; Renwei Wang; Elisabete Weiderpass; Stephanie J Weinstein; Emily White; Alicja Wolk; Jian-Min Yuan; Anne Zeleniuch-Jacquotte; Xuehong Zhang; Katherine A McGlynn; Peter T Campbell; Jill Koshiol
Journal:  Cancer Res       Date:  2019-05-21       Impact factor: 12.701

Review 5.  Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.

Authors:  Alessandro Mantovani; Giovanni Targher
Journal:  Ann Transl Med       Date:  2017-07

6.  Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults.

Authors:  Peter T Campbell; Christina C Newton; Neal D Freedman; Jill Koshiol; Michael C Alavanja; Laura E Beane Freeman; Julie E Buring; Andrew T Chan; Dawn Q Chong; Mridul Datta; Mia M Gaudet; J Michael Gaziano; Edward L Giovannucci; Barry I Graubard; Albert R Hollenbeck; Lindsey King; I-Min Lee; Martha S Linet; Julie R Palmer; Jessica L Petrick; Jenny N Poynter; Mark P Purdue; Kim Robien; Lynn Rosenberg; Vikrant V Sahasrabuddhe; Catherine Schairer; Howard D Sesso; Alice J Sigurdson; Victoria L Stevens; Jean Wactawski-Wende; Anne Zeleniuch-Jacquotte; Andrew G Renehan; Katherine A McGlynn
Journal:  Cancer Res       Date:  2016-10-15       Impact factor: 12.701

Review 7.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

8.  Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.

Authors:  Yi Shen; Harvey Risch; Lingeng Lu; Xiaomei Ma; Melinda L Irwin; Joseph K Lim; Tamar Taddei; Karen Pawlish; Antoinette Stroup; Robert Brown; Zhanwei Wang; Wei Jia; Linda Wong; Susan T Mayne; Herbert Yu
Journal:  Cancer Causes Control       Date:  2020-02-14       Impact factor: 2.506

9.  Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population.

Authors:  Rajani Rai; Kiran L Sharma; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-21       Impact factor: 4.553

Review 10.  Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.

Authors:  Amit G Singal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-15       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.